Nosa Med AB Total Assets
Nosa Med AB total assets. Based on the latest financial reports, Nosa Med AB (NOSA) holds total assets worth Skr64.71 Million SEK (≈ $6.96 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Nosa Med AB (NOSA) market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Nosa Med AB (2016–2025)
Total assets of Nosa Med AB from 2016 to 2025. This chart illustrates how Nosa Med AB's total assets have evolved over time, based on quarterly financial data. See Nosa Med AB stock price for real-time trading data and today's change.
Nosa Med AB - Asset Composition Analysis
Nosa Med AB Total Assets Breakdown (December 2025)
Nosa Med AB total assets breakdown as of December 2025. Nosa Med AB's total assets of Skr64.71 Million consist of 42.8% current assets and 57.3% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 26.7% |
| Accounts Receivable | Skr5.57 Million | 8.6% |
| Inventory | Skr4.80 Million | 7.4% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr23.09 Million | 35.7% |
| Goodwill | Skr9.30 Million | 14.4% |
Asset Composition Trend (2016–2025)
This chart illustrates how Nosa Med AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore NOSA current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nosa Med AB's current assets represent 42.8% of total assets in 2025, an increase from 25.0% in 2016.
- Cash Position: Cash and equivalents constituted 26.7% of total assets in 2025, up from 24.2% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 49.0% of total assets, a decrease from 60.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 35.7% of total assets.
Nosa Med AB Competitors by Total Assets
Key competitors of Nosa Med AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Nosa Med AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.05 | 3.24 | 2.59 |
| Quick Ratio | 1.70 | 2.18 | 2.59 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr14.18 Million | Skr8.75 Million | Skr20.89 Million |
Nosa Med AB - Advanced Valuation Insights
This section examines the relationship between Nosa Med AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.70 |
| Latest Market Cap to Assets Ratio | 0.17 |
| Asset Growth Rate (YoY) | 212.7% |
| Total Assets | Skr64.71 Million |
| Market Capitalization | $11.26 Million USD |
Valuation Analysis
Below Book Valuation: The market values Nosa Med AB's assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Nosa Med AB's assets grew by 212.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Nosa Med AB (2016–2025)
The table below shows the annual total assets of Nosa Med AB from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr64.71 Million ≈ $6.96 Million |
+212.70% |
| 2024-12-31 | Skr20.70 Million ≈ $2.23 Million |
-37.44% |
| 2023-12-31 | Skr33.08 Million ≈ $3.56 Million |
+52.67% |
| 2022-12-31 | Skr21.67 Million ≈ $2.33 Million |
-45.95% |
| 2021-12-31 | Skr40.09 Million ≈ $4.31 Million |
-65.52% |
| 2020-12-31 | Skr116.25 Million ≈ $12.51 Million |
-42.91% |
| 2019-12-31 | Skr203.64 Million ≈ $21.92 Million |
-5.10% |
| 2018-12-31 | Skr214.60 Million ≈ $23.09 Million |
+7.45% |
| 2017-12-31 | Skr199.72 Million ≈ $21.49 Million |
+16.34% |
| 2016-12-31 | Skr171.66 Million ≈ $18.47 Million |
-- |
About Nosa Med AB
Nosa Plugs AB, a medical technology company, develops, manufactures, and sells intranasal breathing products in Sweden, rest of Europe, the United States, Canada, and internationally. The company offers NOSA allergy filter that filters airborne allergens, such as pollen, pet dander, dust, and mold; NOSA smell training, a smell training medical device to improve the sense of smell for individuals … Read more